Stockscreener 앱 받기
4.975
1.33%
0.105
Rezolute Inc 주식(RZLT)의 최신 뉴스
Rezolve AI Pops on Microsoft Investment - Baystreet.ca
Renaissance Technologies LLC Increases Stake in Embraer S.A. (NYSE:ERJ) - Defense World
Realbotix CEO Purchases Additional Common Shares in Open Market - Business Wire
RegTech deals projected to drop by a third for 2024 as investors focus on larger deals - FinTech Global
Zebra Technologies to showcase end-to-end AI solutions at VISION 2024 - Tahawul Tech
Riding the Waves: A Guide to Investing in RELY Stock - The InvestChronicle
Recurly rebrands; new AI solutions - Advanced Television
Take off with The Real Brokerage Inc. (REAX): Get ready for trading - SETE News
Rezolve Ai Expands Customer Base with Three Key Partnerships for AI-Powered E-Commerce Platform - Vancity Buzz
US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment - MSN
Recurly Unveils Suite of AI-Driven Tools to Accelerate Subscriber Growth and Elevate Subscriber Experience - Silicon UK
The Real Brokerage Inc. (REAX) stock on the rise: An overview - US Post News
Ready to Jump After Recent Trade: Remitly Global Inc (RELY) - SETE News
Daiwa Securities Group Inc. Sells 9,000 Shares of Embraer S.A. (NYSE:ERJ) - Defense World
SoftBank-Backed App Rappi Expects to Be IPO-Ready in 12 Months - Bloomberg
Real Brokerage (NASDAQ:REAX) Shares Gap Up to $5.81 - MarketBeat
Market Watch: The Real Brokerage Inc. (REAX)’s Noteworthy Gain, Closing at 5.81 - The Dwinnex
Relay Therapeutics (NASDAQ:RLAY) Shares Gap Up Following Analyst Upgrade - MarketBeat
Where are the Opportunities in (RZLT) - Stock Traders Daily
Federated Hermes Inc. Acquires 1,125,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Quest Partners LLC Increases Holdings in Resideo Technologies, Inc. (NYSE:REZI) - Defense World
Healthy Upside Potential: The Real Brokerage Inc. (REAX) - SETE News
Rezolve AI partners with Creative Dock to boost commerce AI By Investing.com - Investing.com Australia
Rezolve AI and Creative Dock Partner to Drive Digital Innovation in Commerce - GlobeNewswire
Rezolve AI partners with OXID to boost eCommerce with AI By Investing.com - Investing.com Australia
Rezolute, Inc. (NASDAQ:RZLT) Given Average Rating of “Buy” by Brokerages - Defense World
Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $10.75 - MarketBeat
Rezolute Inc (RZLT) rating initates by Guggenheim - Knox Daily
Rezolute (NASDAQ:RZLT) Given New $15.00 Price Target at BTIG Research - Defense World
Rezolute shares maintain Buy rating from H.C. Wainwright on FDA update - Investing.com Canada
Rezolute Gains 13%, Insider Trades Reap Benefit - Simply Wall St
Rezolute (NASDAQ:RZLT) Price Target Raised to $15.00 - MarketBeat
Rezolute Inc (RZLT) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
RZLT Stock Up as FDA Lifts Clinical Holds on Rare Disease Study - Yahoo Finance
RZLT Stock Up as FDA Lifts Clinical Holds on Rare Disease Study - Zacks Investment Research
Rezolute (NASDAQ:RZLT) Receives Buy Rating from HC Wainwright - Defense World
FDA authorises US trial of Rezolute’s drug candidate for congenital hyperinsulinism - Yahoo Finance
US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment - ETHealthWorld
Rezolute's (RZLT) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
RZLT’s latest rating updates from top analysts. - Knox Daily
US FDA lifts partial clinical hold on Rezolute’s blood sugar treatment - WHBL
Peninsula drug maker plots late-stage clinical trial after FDA lifts delay - The Business Journals
Jones Trading maintains Buy rating on Rezolute shares with no price target change - Investing.com Canada
RZLT’s price-to-sales ratio: Is it a good investment opportunity? - US Post News
Healthy Upside Potential: Rezolute Inc (RZLT) - SETE News
FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment - Benzinga
US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment - Reuters.com
Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy (NASDAQ:RZLT) - Seeking Alpha
US FDA lifts partial clinical hold on Rezolute’s low blood sugar treatment - PharmaLive
FDA lifts hold on Rezolute's hyperinsulinism therapy study - Investing.com
US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment - AOL
Rezolute Shares Rise Premarket After FDA Lifts Partial Study Holds - MarketWatch
Rezolute’s RZ358 Advances with FDA Clearance for Study - TipRanks
FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study - StockTitan
Pleasing Signs As A Number Of Insiders Buy Rezolute Stock - Yahoo Finance
Guggenheim Initiates Coverage of Rezolute (RZLT) with Buy Recommendation - Nasdaq
Rezolute (NASDAQ:RZLT) Coverage Initiated by Analysts at Guggenheim - Defense World
Rezolute (NASDAQ:RZLT) Receives New Coverage from Analysts at Guggenheim - MarketBeat
Rezolute to Participate in Upcoming Investor Conferences - StockTitan
BTIG Research gives a Buy recommendation for Rezolute Inc (RZLT) - Knox Daily
Vanguard Group Inc. Grows Stock Position in Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Vanguard Group Inc. Buys 145,700 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute, Inc. (NASDAQ:RZLT) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Contrasting Atreca (NASDAQ:BCEL) and Rezolute (NASDAQ:RZLT) - Defense World
Virtu Financial LLC Acquires Shares of 14,410 Rezolute, Inc. (NASDAQ:RZLT) - Defense World
1.07%
2.16%
자본화:
|
볼륨(24시간):